Macquarie Maintains Outperform on Core Scientific, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 85.1%

Neg 0% Neu 0% Pos 85.1%

Macquarie analyst Paul Golding maintains Core Scientific (NASDAQ:CORZ) with a Outperform and raises the price target from $28 to $35.